Juan Fortea
Juan Fortea
Neurólogo, Hospital de Sant Pau
Verified email at santpau.cat
TitleCited byYear
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis
WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ...
Jama 313 (19), 1924-1938, 2015
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
G Kleinberger, Y Yamanishi, M Suárez-Calvet, E Czirr, E Lohmann, ...
Science translational medicine 6 (243), 243ra86-243ra86, 2014
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis
R Ossenkoppele, WJ Jansen, GD Rabinovici, DL Knol, WM van der Flier, ...
Jama 313 (19), 1939-1950, 2015
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ...
Nature genetics 49 (9), 1373, 2017
sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers
M Suárez‐Calvet, G Kleinberger, MÁA Caballero, M Brendel, A Rominger, ...
EMBO molecular medicine 8 (5), 466-476, 2016
Increased cortical thickness and caudate volume precede atrophy in PSEN1 mutation carriers
J Fortea, R Sala-Llonch, D Bartrés-Faz, B Bosch, A Lladó, N Bargalló, ...
Journal of Alzheimer's Disease 22 (3), 909-922, 2010
Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease
D Alcolea, P Martínez-Lage, P Sánchez-Juan, J Olazarán, C Antúnez, ...
Neurology 85 (7), 626-633, 2015
Relationship between β-secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease
D Alcolea, M Carmona-Iragui, M Suárez-Calvet, MB Sánchez-Saudinós, ...
Journal of Alzheimer's Disease 42 (1), 157-167, 2014
Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia
O Dols-Icardo, A García-Redondo, R Rojas-García, R Sánchez-Valle, ...
Human molecular genetics 23 (3), 749-754, 2013
Cerebrospinal fluid β‐amyloid and phospho‐tau biomarker interactions affecting brain structure in preclinical Alzheimer disease
J Fortea, E Vilaplana, D Alcolea, M Carmona‐Iragui, ...
Annals of neurology 76 (2), 223-230, 2014
Cognitively preserved subjects with transitional cerebrospinal fluid ss-amyloid 1-42 values have thicker cortex in Alzheimer's disease vulnerable areas
J Fortea, R Sala-Llonch, D Bartrés-Faz, A Lladó, C Solé-Padullés, ...
Biological psychiatry 70 (2), 183-190, 2011
Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study
A Leuzy, K Chiotis, SG Hasselbalch, JO Rinne, A de Mendonça, M Otto, ...
Brain 139 (9), 2540-2553, 2016
Correlates of cerebrospinal fluid levels of oligomeric-and total-α-synuclein in premotor, motor and dementia stages of Parkinson’s disease
Y Compta, T Valente, J Saura, B Segura, A Iranzo, M Serradell, C Junqué, ...
Journal of neurology 262 (2), 294-306, 2015
Cerebrospinal fluid biomarkers and memory present distinct associations along the continuum from healthy subjects to AD patients
L Rami, J Fortea, B Bosch, C Solé-Padullés, A Lladó, A Iranzo, ...
Journal of Alzheimer's Disease 23 (2), 319-326, 2011
Different profiles of Alzheimer’s disease cerebrospinal fluid biomarkers in controls and subjects with subjective memory complaints
A Antonell, J Fortea, L Rami, B Bosch, M Balasa, R Sánchez-Valle, ...
Journal of neural transmission 118 (2), 259-262, 2011
Association of cerebral amyloid-β aggregation with cognitive functioning in persons without dementia
WJ Jansen, R Ossenkoppele, BM Tijms, AM Fagan, O Hansson, ...
JAMA psychiatry 75 (1), 84-95, 2018
PLD3 in non-familial Alzheimer's disease
S Heilmann, D Drichel, J Clarimon, V Fernández, A Lacour, H Wagner, ...
Nature 520 (7545), E3, 2015
Neuronal exosomes reveal Alzheimer's disease biomarkers in Down syndrome
ED Hamlett, EJ Goetzl, A Ledreux, V Vasilevko, HA Boger, A LaRosa, ...
Alzheimer's & Dementia 13 (5), 541-549, 2017
Behavioural and psychological symptoms of dementia in Down syndrome: Early indicators of clinical Alzheimer's disease?
AD Dekker, A Strydom, AMW Coppus, D Nizetic, Y Vermeiren, ...
Cortex 73, 36-61, 2015
Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer's disease
D Alcolea, E Vilaplana, J Pegueroles, V Montal, P Sánchez-Juan, ...
Neurobiology of aging 36 (6), 2018-2023, 2015
The system can't perform the operation now. Try again later.
Articles 1–20